Efficacy and safety of a single 400 mg oral dose of cefixime in the treatment of uncomplicated gonorrhea
- 1 March 1989
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 8 (3), 261-262
- https://doi.org/10.1007/bf01965274
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogensAntimicrobial Agents and Chemotherapy, 1986
- In vitro evaluation of cefixime (FK027, FR17027, CL284635): Spectrum against recent clinical isolates, comparative antimicrobial activity, β-lactamase stability, and preliminary susceptibility testing criteriaDiagnostic Microbiology and Infectious Disease, 1986
- The pharmacokinetic and bactericidal characteristics of oral cefiximeClinical Pharmacology & Therapeutics, 1985
- Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporinAntimicrobial Agents and Chemotherapy, 1984